Literature DB >> 27047549

A rare nonsynonymous variant in the lipid metabolic gene HELZ2 related to primary biliary cirrhosis in Chinese Han.

Ping Li1, Guanting Lu1,2, Li Wang1, Ying Cui2, Ziyan Wu1, Si Chen1, Jing Li1, Xiaoting Wen1, Haoze Zhang1, Shijie Mu2, Fengchun Zhang1, Yongzhe Li1.   

Abstract

BACKGROUND: Several genome-wide association studies of primary biliary cirrhosis (PBC) in European and Japanese origins have shown significant association of dozens of genetic loci contributive to the susceptibility of PBC. Most of the loci were related to immune response pathway. In this study, we tested whether the lipid metabolic gene HELZ2 was associated with the pathogenesis of PBC.
METHODS: In 586 PBC cases (358 in case 1 group and 201 in case 2 group) and 726 healthy controls of Chinese Han, six nonsynonymous SNPs were genotyped by MassArray iPLEX. The same control were used for the two groups of PBC cases. Allele frequencies were calculated by χ(2) test based on 2 × 2 contingency tables. All data were analyzed using the PLINK tool set. The odds ratio (OR) and 95 % confidence interval (95 % CI) were calculated, and p values (corrected for multiple testing by Bonferroni adjustment) less than 0.05 were considered statistically significant.
RESULTS: The A allele of rs79267778 was significantly associated with PBC (ORcombined = 4.204 [1.670-10.582], p combined  = 1.87E-04). It changed the amino acid at position 1904 (NM_001037335) from Threonine (ACG) to Methionine (ATG). This site was highly conserved in mammals and predicted to be POSSIBLY DAMAGING with a score of 0.469 by PolyPhen-2. It's further predicted that T1904 M could INCREASE the protein stability with a confidence at 25.18 % under the condition of pH 7.0 and 37 °C.
CONCLUSION: The result was the first time to show evidence of the lipid metabolic gene HELZ2 related to autoimmune disease, at least in PBC of Chinese Han.

Entities:  

Keywords:  HELZ2; Lipid metabollism; Primary biliary cirrhosis; Replication study

Year:  2016        PMID: 27047549      PMCID: PMC4819269          DOI: 10.1186/s13223-016-0120-6

Source DB:  PubMed          Journal:  Allergy Asthma Clin Immunol        ISSN: 1710-1484            Impact factor:   3.406


Background

Primary biliary cirrhosis (PBC) is a common autoimmune liver disease, characteristically associated with anti-mitochondrial antibodies and affecting up to 1 in 1000 women over 40 years of age [1]. Though GWAS studies have found dozens of gene associated with PBC in European and Japanese populations. The genetic factors contributing to the pathogenesis still remain elusive. HELZ2 [OMIM 611265], also known as PRIC285 or PDIP1, is a 2649 amino acid nuclear helicase protein, being a part of the peroxisome proliferator activated receptor α interacting (PRIC) complex [2]. It functions as a nuclear transcriptional coactivator for PPARA and PPARG, as well as other nuclear receptors (RXRA, THRA, THRB) [2, 3]. Inferred from items of gene ontology, this gene is mainly related with cellular lipid metabolic process [4] and liver regeneration [5]. It had been reported that HELZ2’s binding partner, Pparg could regulate the expression of inflammatory genes such as Ccl3, Ccl7, Cxcl10 and Tgtp in mice [6]. This gene also played an important role in innate immune responses [7] and related to immune-related diseases, such as HCV/HIV infection [8], osteoarthritis [9], acne vulgaris [10]. As to itself, HELZ2 possessed the ability to bind proteins important for immune responses, such as BCL6 [11] and ISG15 [12]. Therefore, we inferred that HELZ2 might be associated with autoimmune diseases. Since it could affect liver regeneration, this gene had the promising potentiality to contribute to the pathogenesis of PBC. In order to verify the assumption, we selected 6 nonsynonymous SNPs in the coding region of HELZ2 from 1000 Genomes Project for Asian populations with MAF >2 % and genotyped in 586 PBC cases and 726 healthy controls with Chinese Han. Of the 6 SNPs, the T allele of rs79267778 was found to significantly associated with PBC (ORcombined = 4.204 [1.670−10.582], p = 1.87E−04). It changed the amino acid at position 1904 (NM_001037335) from Threonine (ACG) to Methionine (ATG). Conservation analysis showed this site was highly conserved in mammals and might influence the function of HELZ2. The result was the first time to show evidence of the lipid metabolic gene HELZ2 related to autoimmune disease, at least in PBC of Chinese Han.

Methods

Information of the recruited subjects

The peripheral blood mononuclear cells (PBMCs) of a total of 385 PBC subjects (case 1 group) and 726 age-matched healthy controls were collected by the Rheumatology Department of Peking Union Medical College Hospital and 201 PBC samples (case 2 group) collected from multiple medical centers in China (Table 1). The healthy control were used for the two groups of cases. All patients fulfilled the criteria of the American Association for the Study of Liver Diseases for primary biliary cirrhosis [13]. All patients and controls were unrelated individuals of Han Chinese ethnicity by self-report. The study was approved by the ethics committee of the Peking Union Medical College hospital and all subjects gave informed consent.
Table 1

Samples information

GroupsTotalGendersAges
FemaleMaleMinimumMaximumMean ± SD
Case 138535827167534.69 ± 12.61
Case 220118516188035.53 ± 9.87
Control72668046117934.20 ± 11.25
Samples information

Genotyping of selected SNPs in HELZ2

The genomic DNA of each sample was extracted using QIAamp DNA mini kit (Qiagen, German), and SNP genotyping was performed by the MassArray iPLEX system (Sequenom, USA) at Beijing DnaLead Co. LTD. All procedures were performed according to the manufacturer’s instructions. Approximately 10 ng of genomic DNA was amplified by multiplex PCR and the amplicons subjected to locus-specific single-base extension reactions. The extended products were desalted and transferred to a 384-element SpectroCHIP array. Allele detection was performed using MALDI-TOF mass spectrometry, and the mass spectrograms were analyzed by the MassArray TYPER software v4.0 (Sequenom, USA). 6 SNPs in the coding sequence of HELZ2 were selected for genotyping in the 2 cohorts of Chinese Han (385 cases/726 controls and 201 cases/726 controls) by MassArray iPLEX.

Association analysis of the genotyped SNPs

The genotyped SNPs were tested for Hardy–Weinberg equilibrium (HWE) in the patient and control populations, and any SNPs that deviated from HWE (p < 0.05 in the control group) were excluded from subsequent analyses. Allele frequencies were calculated by χ2 test based on 2 × 2 contingency tables. Since the incidence of PBC was both gender and age related, we took gender and age as covariates in our analysis. All data were analyzed using the PLINK tool set. The odds ratio (OR) and 95 % confidence interval (95 % CI) were calculated, and p values (corrected for multiple testing by Bonferroni adjustment) less than 0.05 were considered statistically significant.

Results

Structural survey of the genomic region with HELZ2

We extracted structural variation data of the region (chr20:62,089,439-62,305,592) from the Database of Genomic Variants [14] and mapped against human reference genome (hg19). HELZ2 was encircled by common deletion polymorphisms. Besides, HELZ2 was located in a region with high recombination rate (cM/Mb) (Fig. 1, upper panel). The LD pattern showed that HELZ2 was in a weakly linked block (Fig. 1 lower panel). Based on these preliminary information, 6 nonsynonymous SNPs in the coding region of HELZ2 were selected from 1000 Genomes Project for Asian populations with MAF >2 % for further genotyping (Table 2).
Fig. 1

Linkage disequilibrium of the region containing HELZ2. Upper panel showed the recombination rate (cM/Mb) (hg19, estimated using all populations of HapMap Phase 2: CEU Utah residents of Northern and Western European ancestry, JPT Japanese in Tokyo, Japan, CHB Han Chinese in Beijing, China, YRI Yoruba in Ibadan, Nigeria. Genetic recombination rates were represented by grey line, and genes within the region were shown in the middle panel. The lower panel showed the pairwise linkage disequilibrium between SNPs in this region. The color of each diamond represented the pairwise linkage between SNPs (measured as r2) defined by the upper left and the upper right sides of the diamond. Shading represented the magnitude of pairwise LD, with a red-to-white gradient reflecting higher to lower LD values

Table 2

Association of SNPs with primary biliary cirrhosis in Chinese Han

SNP IDRisk alleleCohort 1Cohort 2Odds ratio [95 % CI](combined) p value (combined)
Case 1a Controlb p valueCase 2a Controlb p value
rs3810481G0.4070.4620.0540.4340.4620.0860.801 [0.647–0.991]0.044
rs3810483G0.1250.1700.2100.1540.1700.3400.822 [0.599–1.127]0.23
rs79267778T0.0240.0063.62E−030.0190.0062.07E−024.204 [1.670–10.582]1.87E−04
rs3810486A0.3930.4180.1740.4050.4180.3330.820 [1.416–2.347]0.3107
rs6089924A0.0040.0110.0570.0090.0110.4050.377 [0.100–1.426]0.2248
rs114867526A

aTwo groups of PBC cases

bThe same control group

Linkage disequilibrium of the region containing HELZ2. Upper panel showed the recombination rate (cM/Mb) (hg19, estimated using all populations of HapMap Phase 2: CEU Utah residents of Northern and Western European ancestry, JPT Japanese in Tokyo, Japan, CHB Han Chinese in Beijing, China, YRI Yoruba in Ibadan, Nigeria. Genetic recombination rates were represented by grey line, and genes within the region were shown in the middle panel. The lower panel showed the pairwise linkage disequilibrium between SNPs in this region. The color of each diamond represented the pairwise linkage between SNPs (measured as r2) defined by the upper left and the upper right sides of the diamond. Shading represented the magnitude of pairwise LD, with a red-to-white gradient reflecting higher to lower LD values Association of SNPs with primary biliary cirrhosis in Chinese Han aTwo groups of PBC cases bThe same control group

Association of rs79267778 (T1904 M) with PBC in Chinese Han

Of the 6 nonsynonymous SNPs, five were successfully genotyped and one (rs114867526) failed. After analysis, only one SNP, rs79267778, was found to be significantly associated with PBC in the first cohort of PBC samples (358 cases/726 controls) (p = 3.62E−03). In order to validate the associatioin, 201 PBC samples from multiple medical centers were genotyped and compared with same control samples, rs79267778 was also marginally associated with the disease (p = 2.07E−02). After combination analysis, the SNP was strongerly linked with the pathognesis of PBC (ORcombined = 4.204 [1.670–10.582], p = 1.87E−04) (Table 2). rs79267778 located in the largest exon (E9) of HELZ2 (Fig. 2a). The risk allele (A allele) changed the amino acid at position 1904 (NP_001032412) from Threonine (ACG) to Methionine (ATG).
Fig. 2

Diagram of HELZ2 and conservation of rs79267778. a The structure of HELZ2 gene. Green and red boxes represented 5′ UTR and 3′ UTR, respectively. Blue box indicated exons, thin line between boxes represented introns, red line indicated the location of rs114867526. Arrow indicated the direction of transcription. b The alignment of sequences around rs79267778 from 14 species

Diagram of HELZ2 and conservation of rs79267778. a The structure of HELZ2 gene. Green and red boxes represented 5′ UTR and 3′ UTR, respectively. Blue box indicated exons, thin line between boxes represented introns, red line indicated the location of rs114867526. Arrow indicated the direction of transcription. b The alignment of sequences around rs79267778 from 14 species

T1904 M was highly conserved in mammals

Sequences around rs79267778 of 14 species were extract and aligned by the molecular evolutionary genetics analysis software, MEGA v4.0 [15]. The first (A) and second (C) nucleotide of the codon for Threonine (ACG) was highly conserved, with the third varied greatly (Fig. 2b). This mutation was predicted to be POSSIBLY DAMAGING with a score of 0.469 by PolyPhen-2. The web-based software, MuStab (Predicting Mutant Protein Stability Change) was applied to predict if the SNP could influence the stability of HELZ2. Under the condition of pH 7.0 and 37 °C, T1904 M could INCREASE the protein stability with a confidence at 25.18 %.

Discussion

Previous GWAS had identified dozens of loci susceptible to primary biliary cirrhosis in European and Japanese population, such as HLA-DQB1, IL12A, IL12RB2, STAT4, SPIB, IRF5, IKZF3, IL7R, CD80, TNFSF15 and so on [16-19]. The majority of these genes participated in immune responses. Recently, the pivotal gene for energy metabolism, PPARG, has been linked with some kinds of immune-related diseases, such as HCV/HIV infection, osteoarthritis and acne vulgaris. As the important coactivator for PPARG, HELZ2 could bind proteins important for immune responses, such as BCL6 and ISG15. Therefore, we speculated that HELZ2 might be associated with autoimmune diseases. Since it could affect liver regeneration, HELZ2 had the highly potentiality to contribute to the pathogenesis of primary biliary cirrhosis. Using a panel of 6 nonsynonymous SNPs of HELZ2 selected for association in 2 cohorts of Chinese Han, our results showed significant association of a rare SNP, rs79267778 with PBC in Han Chinese (ORcombined = 4.204 [1.670−10.582], p = 1.87E−04). Recently, Fairfax B. reported that a known autoimmune disease locus, rs11171739 at 12q13.2 could trans-regulate the expression of PRIC285 (a well-known name for HELZ2) in B cells and suggested peroxisome proliferator-activated receptor γ (PPARG) signaling might be involved in autoimmune pathogenesis [20]. In this study, a nonsynonymous SNP in the coding region of HELZ2 was identified to significantly associated with PBC.This was the first genetic analysis to associate HELZ2 with the pathogenesis of autoimmune disease, at least for primary biliary cirrhosis in Han Chinese. Except for PBC, there are at lease 2 types of other autoimmune-related liver diseases, such as autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC). The relationship of HELZ2 with AIH and PSC should be elucidated further. Since rs79267778 could change the coding of amino acid at position 1904 of HELZ2, we inferred that it might affect the structure of DNA binding domain or transcription factor binding domain of the protein. According to the conserved domains of HELZ2, it contains 7 domains, AAA domain (519–590), DNA2 domain (642–938), UvrD_C_2 domain (713–915), P-loop_NTPase domain (2150–2189), AAA_11 domain (2152–2399), AAA_12 domain (2406–2611). T1904 M does not locate in any functional domains of the protein. The stability change of HELZ2 was predicted using MuStab for T1904 M. interestingly, the SNP could INCREASE the protein stability with a confidence at 25.18 %. The stabilized HELZ2 could prolong the half-life of its ligand-dependent nuclear receptor transcription coactivator activity. However, precise molecular mechanism of the variant of HELZ2 with primary biliary cirrhosis should be elucidated further.

Conclusion

This was the first evidence to show that the lipid metabolism-related gene, HELZ2 was linked with autoimmune disease, at least for primary biliary cirrhosis in Chinese Han population. Further studies should be performed to reveal the impact of this SNP on the function of HELZ2.
  19 in total

Review 1.  Primary biliary cirrhosis.

Authors:  Marshall M Kaplan; M Eric Gershwin
Journal:  N Engl J Med       Date:  2005-09-22       Impact factor: 91.245

2.  The Pro12Ala polymorphism of the gene for peroxisome proliferator activated receptor-gamma is associated with a lower Global Acne Grading System score in patients with acne vulgaris.

Authors:  K Amr; M Abdel-Hameed; K Sayed; F Nour-Edin; R Abdel Hay
Journal:  Clin Exp Dermatol       Date:  2014-07-01       Impact factor: 3.470

3.  Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways.

Authors:  Chen Zhao; Carilee Denison; Jon M Huibregtse; Steven Gygi; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-11       Impact factor: 11.205

4.  Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.

Authors:  E J Heathcote
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

5.  Isolation and characterization of a transcriptional cofactor and its novel isoform that bind the deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma.

Authors:  Takuya Tomaru; Teturou Satoh; Satoshi Yoshino; Takahiro Ishizuka; Koshi Hashimoto; Tsuyoshi Monden; Masanobu Yamada; Masatomo Mori
Journal:  Endocrinology       Date:  2005-10-20       Impact factor: 4.736

6.  Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis.

Authors:  Xiangdong Liu; Pietro Invernizzi; Yue Lu; Roman Kosoy; Yan Lu; Ilaria Bianchi; Mauro Podda; Chun Xu; Gang Xie; Fabio Macciardi; Carlo Selmi; Sara Lupoli; Russell Shigeta; Michael Ransom; Ana Lleo; Annette T Lee; Andrew L Mason; Robert P Myers; Kevork M Peltekian; Cameron N Ghent; Francesca Bernuzzi; Massimo Zuin; Floriano Rosina; Elisabetta Borghesio; Annarosa Floreani; Roberta Lazzari; Grazia Niro; Angelo Andriulli; Luigi Muratori; Paolo Muratori; Piero L Almasio; Pietro Andreone; Marzia Margotti; Maurizia Brunetto; Barbara Coco; Domenico Alvaro; Maria C Bragazzi; Fabio Marra; Alessandro Pisano; Cristina Rigamonti; Massimo Colombo; Marco Marzioni; Antonio Benedetti; Luca Fabris; Mario Strazzabosco; Piero Portincasa; Vincenzo O Palmieri; Claudio Tiribelli; Lory Croce; Savino Bruno; Sonia Rossi; Maria Vinci; Cleofe Prisco; Alberto Mattalia; Pierluigi Toniutto; Antonio Picciotto; Andrea Galli; Carlo Ferrari; Silvia Colombo; Giovanni Casella; Lorenzo Morini; Nicola Caporaso; Agostino Colli; Giancarlo Spinzi; Renzo Montanari; Peter K Gregersen; E Jenny Heathcote; Gideon M Hirschfield; Katherine A Siminovitch; Christopher I Amos; M Eric Gershwin; Michael F Seldin
Journal:  Nat Genet       Date:  2010-07-18       Impact factor: 38.330

7.  THRAP3 interacts with HELZ2 and plays a novel role in adipocyte differentiation.

Authors:  Akiko Katano-Toki; Tetsurou Satoh; Takuya Tomaru; Satoshi Yoshino; Takahiro Ishizuka; Sumiyasu Ishii; Atsushi Ozawa; Nobuyuki Shibusawa; Takafumi Tsuchiya; Tsugumichi Saito; Hiroyuki Shimizu; Koshi Hashimoto; Shuichi Okada; Masanobu Yamada; Masatomo Mori
Journal:  Mol Endocrinol       Date:  2013-03-22

8.  Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

Authors:  Gideon M Hirschfield; Xiangdong Liu; Chun Xu; Yue Lu; Gang Xie; Yan Lu; Xiangjun Gu; Erin J Walker; Kaiyan Jing; Brian D Juran; Andrew L Mason; Robert P Myers; Kevork M Peltekian; Cameron N Ghent; Catalina Coltescu; Elizabeth J Atkinson; E Jenny Heathcote; Konstantinos N Lazaridis; Christopher I Amos; Katherine A Siminovitch
Journal:  N Engl J Med       Date:  2009-05-20       Impact factor: 91.245

9.  Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator.

Authors:  Sailesh Surapureddi; Songtao Yu; Hengfu Bu; Takashi Hashimoto; Anjana V Yeldandi; Papreddy Kashireddy; Mustapha Cherkaoui-Malki; Chao Qi; Yi-Jun Zhu; M Sambasiva Rao; Janardan K Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-20       Impact factor: 11.205

10.  Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity.

Authors:  Carole Berruyer; Laurent Pouyet; Virginie Millet; Florent M Martin; Aude LeGoffic; Alexandra Canonici; Stéphane Garcia; Claude Bagnis; Philippe Naquet; Franck Galland
Journal:  J Exp Med       Date:  2006-12-04       Impact factor: 14.307

View more
  4 in total

1.  Association of IL12A Expression Quantitative Trait Loci (eQTL) With Primary Biliary Cirrhosis in a Chinese Han Population.

Authors:  Ping Li; Guanting Lu; Ying Cui; Ziyan Wu; Si Chen; Jing Li; Xiaoting Wen; Haoze Zhang; Shijie Mu; Fengchun Zhang; Yongzhe Li
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

2.  Variants in the Promoter Region of HLA-DQA1 were Associated with Idiopathic Membranous Nephropathy in a Chinese Han Population.

Authors:  Xiao-Song Qin; Jian-Hua Liu; Guan-Ting Lyu; Meng-Le Peng; Fu-Ning Yang; Dong-Chun Qin; Yong-Zhe Li; Yong Liu
Journal:  Chin Med J (Engl)       Date:  2017-07-20       Impact factor: 2.628

Review 3.  Recent advances in the diagnosis and treatment of primary biliary cholangitis.

Authors:  Ying-Qiu Huang
Journal:  World J Hepatol       Date:  2016-11-28

4.  Potential biomarkers screening to predict side effects of dexamethasone in different cancers.

Authors:  Da Jiang; Hui Jin; Jing Zuo; Yan Kong; Xue Zhang; Qian Dong; Zhihong Xu; Ying Li
Journal:  Mol Genet Genomic Med       Date:  2020-02-12       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.